Cradle-to-grave life cycle assessment of an ibuprofen analgesic

Alfonsín, 2014, PPCPs in wastewater – update and calculation of characterization factors for their inclusion in LCA studies, J. Clean. Prod., 83, 245, 10.1016/j.jclepro.2014.07.024 Althaus, 2007 Arnold, 2014, Medicating the environment: assessing risks of pharmaceuticals to wildlife and ecosystems, vol. 369 Asgari, 2007, Semibatch production of pharmaceutical grade magnesium stearate: a statistical approach, Chem. Eng. Technol., 30, 1512, 10.1002/ceat.200700163 Ashton, 2004, Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom, Sci. Total Environ., 333, 167, 10.1016/j.scitotenv.2004.04.062 Bound, 2005, Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom, Environ. Health Perspect., 113, 1705, 10.1289/ehp.8315 Boxall, 2012, Pharmaceuticals and personal care products in the environment: what are the big questions?, Environ. Health Perspect., 120, 1221, 10.1289/ehp.1104477 Bradbury, 2004, How important is the role of the physician in the correct use of a drug? An observational cohort study in general practice, Int. J. Clin. Pract., 27 Brodin, 2014, Ecological effects of pharmaceuticals in aquatic systems--impacts through behavioural alterations, Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 369, 10.1098/rstb.2013.0580 Bu, 2016, Pay attention to non-wastewater emission pathways of pharmaceuticals into environments, Chemosphere, 165, 515, 10.1016/j.chemosphere.2016.09.078 Buser, 1999, Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater, Environ. Sci. Technol., 33, 2529, 10.1021/es981014w Bushra, 2010, An overview of clinical pharmacology of Ibuprofen, Oman Med. J., 25, 155, 10.5001/omj.2010.49 Camacho-Muñoz, 2012, Effectiveness of conventional and low-cost wastewater treatments in the removal of pharmaceutically active compounds, Water Air Soil Pollut., 223, 2611, 10.1007/s11270-011-1053-9 Carlsson, 2006, Are pharmaceuticals potent environmental pollutants? Part I: environmental risk assessments of selected active pharmaceutical ingredients, Sci. Total Environ., 364, 67, 10.1016/j.scitotenv.2005.06.035 Collado, 2012, Removal of ibuprofen and its transformation products: experimental and simulation studies, vol. 433, 296 da Silva Júnior, 2017, Alternative technologies to improve solubility and stability of poorly water-soluble drugs, 281 DIMDI EC Ecoinvent Emara, 2019, Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): a review, Integrated Environ. Assess. Manag., 15, 6, 10.1002/ieam.4100 EMEA, 2018 Evonik Fantke, 2017 Ferrando-Climent, 2012, Comprehensive study of ibuprofen and its metabolites in activated sludge batch experiments and aquatic environment, Sci. Total Environ., 438, 404, 10.1016/j.scitotenv.2012.08.073 Finkbeiner, 2013, From the 40s to the 70s—the future of LCA in the ISO 14000 family, Int J LCA, 18, 1, 10.1007/s11367-012-0492-x Finkbeiner, 2006, The new international standards for life cycle assessment: ISO 14040 and ISO 14044, Int J LCA, 11, 80, 10.1065/lca2006.02.002 Gandhi, 2018, Freshwater ecotoxicity characterization factors for aluminum, Int J LCA, 23, 2137, 10.1007/s11367-018-1451-y Geisler, 2004, Production of fine and speciality chemicals. Procedure for the estimation of LCIs, Int J LCA, 9, 101, 10.1007/BF02978569 Guinée Han, 2014, An emission model tracking the life cycle pathways of human pharmaceuticals in Korea, Environ. Health Prev. Med., 19, 46, 10.1007/s12199-013-0352-8 Hebeish, 1988, Chemical factors affecting preparation of carboxymethyl starch, Starch Staerke, 40, 147, 10.1002/star.19880400406 Hischier, 2005, Establishing life cycle inventories of chemicals based on differing data availability (9 pp), Int. J. Life Cycle Assess., 10, 59, 10.1065/lca2004.10.181.7 IPCC, 2013 ISO, 2006 ISO, 2006 Jiménez-González, 2000, Energy sub-modules applied in life-cycle inventory of processes, Clean Prod. Process., 2, 57, 10.1007/s100980050051 Jiménez-González, 2014, The evolution of life cycle assessment in pharmaceutical and chemical applications – a perspective, Green Chem., 16, 3392, 10.1039/C4GC00790E Jiménez-González, 2011, Key green engineering research areas for sustainable manufacturing. A perspective from pharmaceutical and fine chemicals manufacturers, Org. Process Res. Dev., 15, 900, 10.1021/op100327d Jiménez-González, 2000, Methodology for developing gate-to-gate Life cycle inventory information, Int. J. LCA, 5, 153, 10.1007/BF02978615 Kalberlah, 2019, Performance indicator for potential health impact analysis within LCA framework and for environmental product declaration (EPD), Int J LCA, 24, 181, 10.1007/s11367-018-1513-1 Küster, 2014, Pharmaceuticals in the environment: scientific evidence of risks and its regulation, Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci., 369, 10.1098/rstb.2013.0587 Landsiedel, 2002, Assessment of toxicological risks for life cycle assessment and eco-efficiency analysis, Int J LCA, 7, 261, 10.1007/BF02978885 Lang, S.; Nuber, A.; Sanner, A.; Schröder, G. (1987): Process for Preparing Polyvinylpyrrolidone. Applied for by BASF AG. Patent no. CA1273744A; DE3532747A1; EP0215379A2; EP0215379A3; EP0215379B1; JPS6262804A; US4786699A. C08F26/00; C08F26/10; C08F4/00; C08F4/28; C08F4/34; (IPC1-7): C08F26/10. Lautz, 2017, Evaluation of SimpleTreat 4.0: simulations of pharmaceutical removal in wastewater treatment plant facilities, Chemosphere, 168, 870, 10.1016/j.chemosphere.2016.10.123 Lianbao, D. (1992): PROCESS for PREPARING CARBOXYMETHYL STARCH SODIUM. Applied for by SHANGHAI INST ORGANIC CHEM. Patent no. CN1064081A. C08B31/00. Loos, 2008, 23568 Medline, 2019, Ibuprofen. Report on medications Munoz, 2007, A simple model to include human excretion and wastewater treatment in Life Cycle Assessment of food products Ott, 2016, Life cycle assessment of multi-step rufinamide synthesis – from isolated reactions in batch to continuous microreactor networks, Green Chem., 18, 1096, 10.1039/C5GC01932J Parvatker, 2018, Comparative evaluation of chemical life cycle inventory generation methods and implications for life cycle assessment results, ACS Sustain. Chem. Eng., 7, 350, 10.1021/acssuschemeng.8b03656 Parvatker, 2019, Cradle-to-Gate greenhouse gas emissions for twenty anesthetic active pharmaceutical ingredients based on process scale-up and process design calculations, ACS Sustain. Chem. Eng., 7, 6580, 10.1021/acssuschemeng.8b05473 Phadtare, 2014, Hypromellose - a choice of polymer in extended release tablet formulation Piccinno, 2016, From laboratory to industrial scale. A scale-up framework for chemical processes in life cycle assessment studies, J. Clean. Prod., 135, 1085, 10.1016/j.jclepro.2016.06.164 ProScale, 2017, A method for assessing the toxicological potentials of product systems in a life cycle perspective Römpp, 2019 Rosenbaum, 2008, USEtox—the UNEP-SETAC toxicity model. Recommended characterisation factors for human toxicity and freshwater ecotoxicity in life cycle impact assessment, Int. J. Life Cycle Assess., 13, 532, 10.1007/s11367-008-0038-4 Rosenbaum, 2011, USEtox human exposure and toxicity factors for comparative assessment of toxic emissions in life cycle analysis. Sensitivity to key chemical properties, Int. J. Life Cycle Assess., 16, 710, 10.1007/s11367-011-0316-4 Sakanoue, K.; Sanchika, K.; Yasukohchi, T. (2002): Polyethylene Glycol and Process for Producing the Same. Applied for by NOF CORP. Patent no. DE60200495T2; EP1245608A1; EP1245608B1; US2002193640A1; US6620976B2; US2003216602A1; US6812367B2. C08G65/26. Schumacher, K.; Flesch, J.; Hamm, V. (2006): PURIFICATION OF FINELY DIVIDED, PYROGENICALLY PREPARED METAL OXDE PARTICLES. Applied for by DEGUSSA AG, DUSSELDORF (DE). Patent no. US 2006/0286028A1. B01J8/00; C01B13/14; C01B33/18; C01F7/02; C01G23/07; B01F1/00. Sheldon, 2017, The E factor 25 years on. The rise of green chemistry and sustainability, Green Chem., 19, 18, 10.1039/C6GC02157C Siegert, 2019 Siegert, 2019, Harmonized rules for future LCAs on pharmaceutical products and processes, Int. J. Life Cycle Assess., 24, 1040, 10.1007/s11367-018-1549-2 Siegert, 2020, Addressing the use and end-of-life phase of pharmaceutical products in life cycle assessment, Int J LCA, 120, 75 Sinclair, 2000, Over-the-counter ibuprofen. How and why is it used?, Int. J. Pharm. Pract., 8, 121, 10.1111/j.2042-7174.2000.tb00996.x Slack, 2005, Household hazardous waste in municipal landfills: contaminants in leachate, Sci. Total Environ., 337, 119, 10.1016/j.scitotenv.2004.07.002 Strauch, 2011, Invisible pollution, AAOHN J., 59, 525 Struijs, 2014 Thinkstep, 2020 Tixier, 2003, Occurrence and fate of carbamazepine, clofibric acid, diclofenac, ibuprofen, ketoprofen, and naproxen in surface waters, Environ. Sci. Technol., 37, 1061, 10.1021/es025834r UBA, 2019 Ullmann, 2000 United Nations van Oers WBCSD, 2014 Wernet, 2016, The ecoinvent database version 3 (part I): overview and methodology, Int J LCA, 21, 1218, 10.1007/s11367-016-1087-8 Wernet, 2010, Life cycle assessment of fine chemical production: a case study of pharmaceutical synthesis, Int J LCA, 15, 294, 10.1007/s11367-010-0151-z